Yangtze River Pharmaceutical Group Group and its delegation went to Shenzhen Bay Laboratory for research and exchange

In the morning of August 20, Park Yongji, the head of South China operation of Yangtze River Pharmaceutical Group Group, Liu Zhiqiang, the director of the research institute of Guangzhou Hairui Pharmaceutical Co., Ltd. (hereinafter referred to as "Hairui Pharmaceutical"), and others went to Shenzhen Bay Laboratory for research and exchange. Li Zigang, Executive Director of Pingshan Biomedical Research and Transformation Center (hereinafter referred to as "Pingshan Center") at Shenzhen Bay Laboratory, Chen Jie'an, Minister of Scientific Research Department, and Yin Feng, a researcher, participated in the discussion and exchange.

On the morning of August 8th, Park Yongji, head of operations in South China of Yangtze River Pharmaceutical Group, Liu Zhiqiang, director of the research institute of Guangzhou Hairui Pharmaceutical Co., Ltd. (hereinafter referred to as "Hairui Pharmaceutical"), and other entourage went to Shenzhen Bay Laboratory for research and exchange. Li Zigang, Executive Director of Pingshan Biomedical R&D and Transformation Center (hereinafter referred to as "Pingshan Center") of Shenzhen Bay Laboratory, Chen Jiean, Director of Scientific Research Department, and Yin Feng, researcher attended the symposium.

图片1.jpg

At the meeting, Executive Director Li Zigang expressed a warm welcome to Yangzijiang Pharmaceutical Group, and Cheng Jiefeng, head of business development of Hairui Pharmaceutical Research Institute, introduced the group's development history, quality policy, R&D team and core products (such as gastric soda granules, Lanqin oral liquid).

Professor Chen Jie'an of Pingshan Center introduced the construction goals and history, external cooperation and research team of Shenzhen Bay Laboratory and Pingshan Center, and introduced the team strength and technical advantages of Pingshan Center in chemical and biological drug research with Executive Director Li Zigang on the development of new anti-tumor drug candidates and combination drug research, peptide drug development and research.

图片2.jpg

Finally, the two sides made detailed exchanges on drug R&D ideas, drug screening, platform technology, chemical drugs and biological drugs from R&D to industrialization, and expressed their intention to cooperate in scientific research projects and industrialization.

Written by| Pingshan Biomedical R&D and Transformation Center

Edit | White